Tapan Behl
Tapan Behl
Dr.
Verified email at chitkara.edu.in
Title
Cited by
Cited by
Year
Implication of oxidative stress in progression of diabetic retinopathy
T Behl, I Kaur, A Kotwani
Survey of ophthalmology 61 (2), 187-196, 2016
1222016
Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy
T Behl, A Kotwani
Pharmacological research 99, 137-148, 2015
1082015
Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
A Gupta, K Shah, MJ Oza, T Behl
Biomedicine & Pharmacotherapy 109, 484-492, 2019
492019
The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
T Behl, I Kaur, S Bungau, A Kumar, MS Uddin, C Kumar, G Pal, ...
Life Sciences, 118075, 2020
472020
Ginkgolide A attenuates homocysteine-induced endothelial dysfunction in porcine coronary arteries
W Zhou, H Chai, A Courson, PH Lin, AB Lumsden, Q Yao, C Chen
Journal of vascular surgery 44 (4), 853-862, 2006
452006
Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy
T Behl, A Kotwani
Life sciences 176, 1-9, 2017
352017
Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy
T Behl, A Kotwani
Life sciences 176, 1-9, 2017
352017
Chinese herbal drugs for the treatment of diabetic retinopathy
T Behl, A Kotwani
Journal of Pharmacy and Pharmacology 69 (3), 223-235, 2017
342017
Implications of the endogenous PPAR-gamma ligand, 15-deoxy-delta-12, 14-prostaglandin J2, in diabetic retinopathy
T Behl, I Kaur, H Goel, A Kotwani
Life sciences 153, 93-99, 2016
272016
Omega‐3 fatty acids in prevention of diabetic retinopathy
T Behl, A Kotwani
Journal of Pharmacy and Pharmacology 69 (8), 946-954, 2017
252017
Significance of the antiangiogenic mechanisms of thalidomide in the therapy of diabetic retinopathy
T Behl, I Kaur, H Goel, A Kotwani
Vascular pharmacology 92, 6-15, 2017
252017
Possible role of endostatin in the antiangiogenic therapy of diabetic retinopathy
T Behl, A Kotwani
Life sciences 135, 131-137, 2015
252015
Revisiting the amyloid cascade hypothesis: From anti-Aβ therapeutics to auspicious new ways for Alzheimer’s disease
M Uddin, M Kabir, M Rahman, T Behl, P Jeandet, GM Ashraf, A Najda, ...
International Journal of Molecular Sciences 21 (16), 5858, 2020
222020
Downregulated brain-derived neurotrophic factor-induced oxidative stress in the pathophysiology of diabetic retinopathy
T Behl, A Kotwani
Canadian journal of diabetes 41 (2), 241-246, 2017
222017
Nutraceuticals in neurological disorders
R Makkar, T Behl, S Bungau, G Zengin, V Mehta, A Kumar, M Uddin, ...
International Journal of Molecular Sciences 21 (12), 4424, 2020
212020
Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates
M Mukhtar, M Bilal, A Rahdar, M Barani, R Arshad, T Behl, C Brisc, ...
Chemosensors 8 (4), 117, 2020
182020
Emerging proof of protein misfolding and interactions in multifactorial Alzheimer's disease
MS Uddin, A Al Mamun, M Rahman, T Behl, A Perveen, A Hafeez, ...
Current Topics in Medicinal Chemistry 20 (26), 2380-2390, 2020
162020
Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease
MS Uddin, MA Rahman, MT Kabir, T Behl, B Mathew, A Perveen, ...
Iubmb Life 72 (9), 1843-1855, 2020
152020
Synthesis of physically crosslinked PVA/Chitosan loaded silver nanoparticles hydrogels with tunable mechanical properties and antibacterial effects
A Kumar, T Behl, S Chadha
International journal of biological macromolecules 149, 1262-1274, 2020
152020
Mechanisms of prolonged lithium therapy-induced nephrogenic diabetes insipidus
T Behl, A Kotwani, I Kaur, H Goel
European journal of pharmacology 755, 27-33, 2015
152015
The system can't perform the operation now. Try again later.
Articles 1–20